Cytotoxic and antitumor peptides as novel chemotherapeutics

Nat Prod Rep. 2021 Jan 1;38(1):7-17. doi: 10.1039/d0np00019a. Epub 2020 Aug 10.

Abstract

Covering: up to 2020Treatment resistance and drug-induced refractory malignancies pose significant challenges for current chemotherapy drugs. There have been increasing research efforts aimed at developing novel chemotherapeutics, especially from natural products and related derivatives. Natural cytotoxic peptides, an emerging source of chemotherapeutics, have exhibited the advantage of overcoming drug resistance and displayed broad-spectrum antitumor activities in the clinic. This highlight examines the increasingly popular cytotoxic peptides from isolated natural products. In-depth review of several peptides provides examples for how this novel strategy can lead to the improved anti-tumor effects. The mechanisms and current application of representative natural cytotoxic peptides (NCPs) have also been discussed, with a particular focus on future directions for interdisciplinary research.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Antineoplastic Agents / chemistry
  • Antineoplastic Agents / pharmacology*
  • Apoptosis / drug effects
  • Biological Products / pharmacology
  • Cell Membrane / drug effects
  • Cytotoxins / pharmacology
  • Humans
  • Immunoconjugates / chemistry
  • Immunoconjugates / pharmacology*
  • Neoplasms / drug therapy
  • Neoplasms / pathology*
  • Neoplasms / therapy
  • Neovascularization, Pathologic / drug therapy
  • Oncolytic Virotherapy / methods
  • Peptides / chemistry*
  • Peptides / pharmacology*

Substances

  • Antineoplastic Agents
  • Biological Products
  • Cytotoxins
  • Immunoconjugates
  • Peptides